Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.52
-0.04-1.56%
Last update: Oct 5, 7:15 AM
$2.66
0.103.91%
Kiora Pharmaceuticals Inc (KPRX) Stock Price, Quote, News & History
KPRXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kiora Pharmaceuticals (NASDAQ:KPRX) through any online brokerage.
Other companies in Kiora Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Kiora Pharmaceuticals has a consensus price target of $10.00.
The stock price for Kiora Pharmaceuticals (NASDAQ: KPRX) is $2.66 last updated October 5, 2026 at 7:15 AM EDT.
There are no upcoming dividends for Kiora Pharmaceuticals.
Kiora Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Kiora Pharmaceuticals.
Kiora Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
